Latest features in GaBI Journal, 2016, Issue 3

Author(s): Professor Philip D Walson, MD

The informed, appropriate use of follow-on pharmacological agents can provide significant cost savings for patients and payers. These savings can then be used by governments and patients to increase access to health care. However, the actual savings realized depend on a complex series of factors including how ‘similar’ the products actually are to the innovator […]

Read more →